Neonatal bone marrow interstitial fluid supports expansion and osteogenic ability of human bone marrow mesenchymal stromal cells

Junfeng Zhang , Tengjiao Ma , Lan Ke , Huan Zhang , Jiaxin Hu , Shunping Li , Hailong Wang , Anming Meng

Bone Research ›› 2025, Vol. 13 ›› Issue (1) : 102

PDF
Bone Research ›› 2025, Vol. 13 ›› Issue (1) :102 DOI: 10.1038/s41413-025-00496-z
Article
research-article

Neonatal bone marrow interstitial fluid supports expansion and osteogenic ability of human bone marrow mesenchymal stromal cells

Author information +
History +
PDF

Abstract

The bone marrow microenvironment is critical for the maintenance and functionality of stem/progenitor cells, which are essential for bone development and regeneration. However, the composition and potential use of bone marrow interstitial fluid have not been well explored. In this study, we report the role of neonatal bovine bone marrow interstitial fluid (NBIF) in enhancing the bone regeneration capacity of human bone marrow mesenchymal stem cells (hBMSCs). Unlike adult bovine bone marrow interstitial fluid (ABIF), NBIF-fed hBMSCs exhibit enhanced self-renewal and osteogenic potential and bone marrow homing ability, along with transcriptome changes as compared to hBMSCs cultured in standard fetal bovine serum (FBS) supplemented medium. Mass spectrometry analysis reveals that multiple secreted factors associated with tissue repair and bone development are enriched in NBIF compared to FBS and ABIF. The combined use of NBIF-enriched Nerve Growth Factor (NGF), Lactoferrin (LTF), and High Mobility Group Protein B1 (HMGB1), together with Insulin-Like Growth Factor 1(IGF1) for culturing hBMSCs in the presence of FBS can enhance osteogenic potential and bone marrow homing ability, mimicking NBIF’s effects. These findings highlight the role of interstitial fluid in the bone marrow microenvironment and its potential to optimize stem cell-based therapies.

Cite this article

Download citation ▾
Junfeng Zhang, Tengjiao Ma, Lan Ke, Huan Zhang, Jiaxin Hu, Shunping Li, Hailong Wang, Anming Meng. Neonatal bone marrow interstitial fluid supports expansion and osteogenic ability of human bone marrow mesenchymal stromal cells. Bone Research, 2025, 13(1): 102 DOI:10.1038/s41413-025-00496-z

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Huang B, et al. . Osteoblasts secrete Cxcl9 to regulate angiogenesis in bone. Nat. Commun., 2016, 713885

[2]

Li CJ, et al. . Senescent immune cells release grancalcin to promote skeletal aging. Cell Metab., 2022, 34: 184-185.

[3]

Morrison SJ, Scadden DT. The bone marrow niche for haematopoietic stem cells. Nature, 2014, 505: 327-334.

[4]

Ma S, et al. . Skeletal muscle-derived extracellular vesicles transport glycolytic enzymes to mediate muscle-to-bone crosstalk. Cell Metab., 2023, 35: 2028-2043.e2027.

[5]

Sullivan MR, et al. . Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. Elife, 2019, 8: e44235

[6]

Mittenbuhler MJ, et al. . Isolation of extracellular fluids reveals novel secreted bioactive proteins from muscle and fat tissues. Cell Metab., 2023, 35: 535-549.e537.

[7]

Cuminetti V, Arranz L. Bone marrow adipocytes: the enigmatic components of the hematopoietic stem cell niche. J. Clin. Med, 2019, 8: 707

[8]

Guillerman RP. Marrow: red, yellow and bad. Pediatr. Radio., 2013, 43: S181-S192.

[9]

Gurevitch O, Slavin S, Feldman AG. Conversion of red bone marrow into yellow - Cause and mechanisms. Med Hypotheses, 2007, 69: 531-536.

[10]

Jun Ling S, et al. . Determination of bone marrow cell morphology in rat. Cell Mol. Biol., 2023, 69: 41-44.

[11]

Justesen J, et al. . Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology, 2001, 2: 165-171.

[12]

Mendez-Ferrer S, et al. . Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature, 2010, 466: 829-834.

[13]

Moore SG, Dawson KL. Red and yellow marrow in the femur: age-related changes in appearance at MR imaging. Radiology, 1990, 175: 219-223.

[14]

Naveiras O, et al. . Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature, 2009, 460: 259-263.

[15]

Zhou J, Shi Y. Mesenchymal stem/stromal cells (MSCs): origin, immune regulation, and clinical applications. Cell Mol. Immunol., 2023, 20: 555-557.

[16]

Banfi A, et al. . Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp. Hematol., 2000, 28: 707-715.

[17]

Baxter MA, et al. . Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells, 2004, 22: 675-682.

[18]

Wagner W, Ho AD, Zenke M. Different facets of aging in human mesenchymal stem cells. Tissue Eng. Rev., 2010, 16: 445-453.

[19]

Wagner W, et al. . Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One, 2008, 3: e2213

[20]

Rombouts WJ, Ploemacher RE. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia, 2003, 17: 160-170.

[21]

Shan Y, et al. . Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges. Signal Transduct. Target Ther., 2024, 9: 242

[22]

Tsai TL, Li WJ. Identification of bone marrow-derived soluble factors regulating human mesenchymal stem cells for bone regeneration. Stem Cell Rep., 2017, 8: 387-400.

[23]

Gnecchi M, Danieli P, Malpasso G, Ciuffreda MC. Paracrine mechanisms of mesenchymal stem cells in tissue repair. Methods Mol. Biol., 2016, 1416: 123-146.

[24]

Konala VB, et al. . The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration. Cytotherapy, 2016, 18: 13-24.

[25]

Ortiz LA, et al. . Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc. Natl. Acad. Sci. USA, 2007, 104: 11002-11007.

[26]

de Castro LF, et al. . Secreted frizzled related-protein 2 (Sfrp2) deficiency decreases adult skeletal stem cell function in mice. Bone Res., 2021, 9: 49

[27]

Janda CY, et al. . Surrogate Wnt agonists that phenocopy canonical Wnt and beta-catenin signalling. Nature, 2017, 545: 234-237.

[28]

Zhou BO, Yue R, Murphy MM, Peyer JG, Morrison SJ. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell, 2014, 15: 154-168.

[29]

Huang Z, et al. . Articular cartilage regeneration via induced chondrocyte autophagy by sustained release of leptin inhibitor from thermo-sensitive hydrogel through STAT3/REDD1/mTORC1 Cascade. Adv. Health Mater., 2023, 12e2302181

[30]

Yu X, et al. . Cellular hypoxia promotes osteogenic differentiation of mesenchymal stem cells and bone defect healing via STAT3 signaling. Cell Mol. Biol. Lett., 2019, 24: 64

[31]

Yue R, Zhou BO, Shimada IS, Zhao Z, Morrison SJ. Leptin receptor promotes adipogenesis and reduces osteogenesis by regulating mesenchymal stromal cells in adult bone marrow. Cell Stem Cell, 2016, 18: 782-796.

[32]

Zhou S, et al. . STAT3 is critical for skeletal development and bone homeostasis by regulating osteogenesis. Nat. Commun., 2021, 126891

[33]

Dong F, et al. . Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction. Circulation, 2012, 126: 314-324.

[34]

Gan J, et al. . CXCR4-Expressing mesenchymal stem cells derived nanovesicles for rheumatoid arthritis treatment. Adv. Health Mater., 2024, 13e2303300

[35]

Kucia M, et al. . Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. Leukemia, 2005, 19: 1118-1127.

[36]

Meister A. Glutathione-ascorbic acid antioxidant system in animals. J. Biol. Chem., 1994, 269: 9397-9400.

[37]

Ren G, et al. . Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell, 2008, 2: 141-150.

[38]

Milenkovic J, Milojkovic M, Jevtovic Stoimenov T, Djindjic B, Miljkovic E. Mechanisms of plasminogen activator inhibitor 1 action in stromal remodeling and related diseases. Biomed. Pap. Med. Fac. Univ. Palacky., 2017, 161: 339-347

[39]

Lin SL, et al. . Mini Review: Molecular Interpretation of the IGF/IGF-1R Axis in Cancer Treatment and Stem Cells-Based Therapy in Regenerative Medicine. Int. J. Mol. Sci, 2022, 23: 11781

[40]

Zhou L, et al. . ATP-binding cassette g1 regulates osteogenesis via Wnt/beta-catenin and AMPK signaling pathways. Mol. Biol. Rep., 2020, 47: 7439-7449.

[41]

Wynn RF, et al. . A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood, 2004, 104: 2643-2645.

[42]

Chang Q, et al. . High-mobility group box 1 accelerates distraction osteogenesis healing via the recruitment of endogenous stem/progenitor cells. Cytotherapy, 2023, 25: 946-955.

[43]

Lee G, et al. . Fully reduced HMGB1 accelerates the regeneration of multiple tissues by transitioning stem cells to G(Alert). Proc. Natl. Acad. Sci. USA, 2018, 115: E4463-E4472. DOI:

[44]

Pellegrini L, et al. . HMGB1 and repair: focus on the heart. Pharm. Ther., 2019, 196: 160-182.

[45]

Tamai K, et al. . PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia. Proc. Natl. Acad. Sci. USA, 2011, 108: 6609-6614.

[46]

Bertheloot D, Latz E. HMGB1, IL-1alpha, IL-33 and S100 proteins: dual-function alarmins. Cell Mol. Immunol., 2017, 14: 43-64.

[47]

Nefla M, Holzinger D, Berenbaum F, Jacques C. The danger from within: alarmins in arthritis. Nat. Rev. Rheumatol., 2016, 12: 669-683.

[48]

Yuan S, Liu Z, Xu Z, Liu J, Zhang J. High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies. J. Hematol. Oncol., 2020, 13: 91

[49]

Xu K, et al. . HMGB1/STAT3/p65 axis drives microglial activation and autophagy exert a crucial role in chronic Stress-Induced major depressive disorder. J. Adv. Res., 2024, 59: 79-96.

[50]

Chang Y, et al. . Lactoferrin mediates enhanced osteogenesis of adipose-derived stem cells: innovative molecular and cellular therapy for bone repair. Int. J. Mol. Sci, 2023, 24: 1749

[51]

Icriverzi M, et al. . Lactoferrin in bone tissue regeneration. Curr. Med Chem., 2020, 27: 838-853.

[52]

Trybek G, et al. . Impact of lactoferrin on bone regenerative processes and its possible implementation in oral surgery - a systematic review of novel studies with metanalysis and metaregression. BMC Oral. Health, 2020, 20232

[53]

Wei L, et al. . Lactoferrin is required for early B cell development in C57BL/6 mice. J. Hematol. Oncol., 2021, 14: 58

[54]

Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev. Neurosci., 2001, 24: 1217-1281.

[55]

Gao X, et al. . Leptin receptor(+) cells promote bone marrow innervation and regeneration by synthesizing nerve growth factor. Nat. Cell Biol., 2023, 25: 1746-1757.

[56]

Lian M, et al. . Nerve growth factor-preconditioned mesenchymal stem cell-derived exosome-functionalized 3D-printed hierarchical porous scaffolds with neuro-promotive properties for enhancing innervated bone regeneration. ACS Nano, 2024, 18: 7504-7520.

[57]

Van Pham P, et al. . Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications. Cell Tissue Bank, 2016, 17: 289-302.

[58]

Boregowda SV, Krishnappa V, Phinney DG. Isolation of mouse bone marrow mesenchymal stem cells. Methods Mol. Biol., 2016, 1416: 205-223.

[59]

Patel C, et al. . A new method of bone stromal cell characterization by Flow Cytometry. Curr. Protoc., 2022, 2: e400

Funding

Guangzhou National Laboratory (grant #QNPG2317)

National Natural Science Foundation of China (National Science Foundation of China)(31988101)

Guangzhou National Laboratory (grant #GZNL2025C02022)

RIGHTS & PERMISSIONS

The Author(s)

PDF

32

Accesses

0

Citation

Detail

Sections
Recommended

/